Zeatin Prevents Amyloid β-Induced Neurotoxicity and Scopolamine-Induced Cognitive Deficits

다국어 초록 (Multilingual Abstract)

The antioxidative and protective effects of zeatin against amyloid β-protein (Aβ)-induced neurotoxicity were investigated using PC12 cells. Zeatin showed antioxidative and cell protective effects against Aβ-induced neurotoxicity. In this study, we also evaluated the effect of zeatin on learning and memory capacity in vivo using ICR mice with amnesia induced by scopolamine (1 mg/kg of body weight). Zeatin, when administered to mice at 4.5 mg/kg of body weight, significantly ameliorated scopolamine-induced amnesia as measured in both the passive avoidance test and Y-maze test. Injecting mice with scopolamine impaired performance on the passive avoidance test (48 ± 4.5% decrease) and on the Y-maze test (12 ± 1.3% decrease). In contrast, mice treated with zeatin before scopolamine injections were protected from these changes (5–34% decrease in step-through latency; 1–4% decrease in alternation behavior). The present results suggest a possible chemopreventive role of zeatin in Alzheimer's disease.

참고문헌 (Reference)

1 Eastwood MA, "nteraction of dietary antioxidants in vivo: howfruit and vegetables prevent disease?" 527-530, 1999

2 Price P, "Use of the tetrazolium assay in measuringthe response of human tumor cells to ionizing radiation" 1392-1396, 1990

3 Selkoe DJ, "Translating cell biology into therapeutic advances inAlzheimer’s disease" 23-31, 1999

4 Canevari L, "Toxicity of amyloid betapeptide: tales of calcium, mitochondria, and oxidative stress" 637-650, 2004

5 Donovan FM, "Thrombininduces apoptosis in cultured neurons and astrocytes via apathway requiring tyrosine kinase and Rho A activities" 5316-5326, 1997

6 Kasa P, "The cholinergic system inAlzheimer’s disease" 511-535, 1997

7 Banowetz GM, "Temperature effect on cytokininaccumulation and kernel mass in dwarf wheat" 303-307, 1999

8 Alvarez A, "Stable complex involving acetylcholinesterase and amyloid-" 3213-3223, 1998

9 Gue M, "Sex differences in learning deficits induced byprenatal stress in juvenile rats" 149-157, 2004

10 Broadwell RD, "Serum proteins bypass the bloodbrainfluid barriers for extra-cellular entry to the central nervoussystem" 245-263, 1993

11 Branchi I, "Scopolamine effects on ultrasonicvocalization emission and behavior in the neonatalmouse" 9-16, 2004

12 Yan SD, "RAGE and amyloid-" 685-691, 1996

13 Heo HJ, "Protective effect of 4" 194-201, 2001

14 Mattson MP, "Presenilins, theendoplasmic reticulum, and neuronal apoptosis in Alzheimer’sdisease" 1-14, 1998

15 Markesbery WR, "Oxidative alterations in Alzheimer’sdisease" 133-146, 1999

16 Park CH, "Novel acetylcholinesterase and antiamnesic activities of dehydroevodiamine,a constituent of Evodia rutaecarpa" 405-409, 1996

17 Shoffner JM, "Mitochondrial DNA variants observed in Alzheimer’s disease and Parkinson disease patients" 171-184, 1993

18 Yankner BA:, "Mechanisms of neuronal degeneration inAlzheimer’s disease" 921-932, 1996

19 Ho-Jin Heo, "Inhibitory Effect of Zeatin, Isolated from Fiatoua villosa, on Acetylcholinesterase Activity from PC12 Cells" 한국분자세포생물학회 13 (13): 113-117, 2002

20 Marcus DL, "Increased peroxidation and reducedantioxidant enzyme activity in Alzheimer’s disease" 40-44, 1998

21 Pike CJ, "In vitro agingof" 311-314, 1991

22 Espallergues J, "Hyposensitivity to the amnesic effects of scopolamineor amyloid" 131-134, 2008

23 Behl C, "Hydrogen peroxide mediatesamyloid" 817-827, 1994

24 Behl C, "Glucocorticoids enhance oxidative stress induced celldeath in hippocampal neurons in vitro" 101-106, 1997

25 Floyd RA, "Free radical damage to protein and DNA:mechanisms involved and relevant observations on brain undergoingoxidative stress" 22-27, 1992

26 Fotsis T, "Flavonoids, dietary-derivedinhibitors of cell proliferation and in vitro angiogenesis" 2916-2921, 1997

27 Gerritsen ME, "Flavonoids in the Living System" Plenum Press 183-190, 1998

28 Pappolla MA, "Evidence of oxidative stress and in vivo neurotoxicityof beta-amyloid in a transgenic mouse model of Alzheimer’s disease:a chronic oxidative paradigm for testing antioxidant therapiesin vivo" 871-877, 1998

29 Kasa P Sr, "Effects ofamyloid-beta on cholinergic and acetylcholinesterase-positivecells in cultured basal forebrain neurons of embryonic rat brain" 73-82, 2004

30 Heo HJ, "Effects of oleamide on cholineacetyltransferase and cognitive activities" 1284-1291, 2003

31 Middleton E Jr, "Effect of plant flavonoids on immune and inflammatorycell function" 175-182, 1998

32 Harris ME, "Direct evidence of oxidative injury produced by the Alzheimerbeta-amyloid peptide (1–40) in cultured hippocampal neurons" 193-202, 1995

33 Benzi G, "Are reactive oxygen species involved inAlzheimer’s disease?" 661-674, 1995

34 Grundman M, "Antioxidant strategiesfor Alzheimer’s disease" 191-202, 200261

35 Chan WH, "Antiapoptotic effects of curcumin on photosensitizedhuman epidermal carcinoma A431 cells" 200-212, 2004

36 Hensley K, "Amyloid- peptide spin trapping II: evidence for decomposition of the PBNspin adduct" 489-493, 1995

37 Hardy JA, "Alzheimer’s disease: the amyloid cascadehypothesis" 184-185, 1992

38 Selkoe DJ:, "Alzheimer’s disease: genes, proteins, and therapy" 741-766, 2001

39 Smith MA, ": Carbonyl related posttranslationalmodification of neurofilament protein in the neurofibrillarypathology of Alzheimer’s disease" 2660-2666, 1995